Quantcast

Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivan’s 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award

February 23, 2009

MARQUETTE, Mich. and GREENVILLE, N.C., Feb. 23 /PRNewswire/ — Pioneer
Surgical Technology, Inc., a leading innovator in the design and manufacture
of spinal and orthopaedic implants, instruments and biologic products, today
announced that it has won the prestigious Frost & Sullivan 2009 North American
Technology Innovation of the Year Award for the E-Matrix(TM) Tissue Scaffold,
recently launched in the United States.

The patented E-Matrix technology provides a bioscaffold for leading edge
biologic products in orthopaedics and other therapeutic areas. Pioneer’s CEO
and President, Jeff Millin, noted, “This award reflects Pioneer’s commitment
to deliver on innovation that benefits patients and surgeons, and is
cost-effective for the healthcare system.” E-Matrix is the result of over ten
years of dedicated research and development.

Ronald S. Hill, PhD, Vice President of Research and Development, says,
“Frost & Sullivan is world renowned for technology analysis and after an
exhaustive review of products in this therapeutic category, Pioneer has been
recognized for the significance and potential of this innovative technology to
become the market leader.”

Pioneer continues to focus on commercializing these novel technologies and
recently launched a bone graft substitute to the US orthopaedic market
utilizing the E-Matrix(TM) bioscaffold combined with nanOss(TM), a proprietary
nano-crystalline hydroxyapatite.

About Pioneer Surgical Technology

Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan,
with Biologic R&D and manufacturing facilities in North Carolina and
Massachusetts, is a dynamic medical device firm with a full line of motion
preservation devices available commercially in Europe or under clinical
evaluation in the U.S., in addition to diverse spinal fusion systems and
advanced biologics. Pioneer’s signature articulating P3(TM) Technology
– Pioneer PEEK-on-PEEK, is key to the leading nucleus replacement system
NuBac(TM) currently in U.S. clinical trials. Pioneer’s focus on innovation has
resulted in over 100 U.S. and foreign patents with numerous patents pending.
Pioneer focuses on developing products which are easier and faster for the
surgeon, cost effective for the health care system, and provide better patient
outcomes.

SOURCE Pioneer Surgical Technology, Inc.


Source: newswire



comments powered by Disqus